Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
CuraGen Corp. (CRGN)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: CRGN
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
Curagen: Positive Results at ASCO 2009
Jul 7
•
Ohad Hammer
•
2 Comments
FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
Jun 1
•
Mike Havrilla
•
2 Comments
Two Potential Mega Biotech Deals Fuel Industry Hopes
May 31
•
The Burrill Report
•
2 Comments
Top Biotech Picks for ASCO 2009 (Part II)
May 27
•
Ohad Hammer
•
2 Comments
Top Biotech Picks for ASCO 2009 (Part I)
May 27
•
Ohad Hammer
•
2 Comments
CuraGen Presents an Opportune Time to Exit
May 18
•
Greenbackd
•
1 Comment
Clinical Trial Updates: Cancer Drugs in Focus as ASCO Approaches
May 18
•
Mike Havrilla
•
1 Comment
Four Biotech Stocks with 'Free' Pipelines
May 14
•
Zacks.com
•
Comment!
CuraGen Caught in the Middle
Apr 11
•
Zacks.com
•
Comment!
Performance and Update of Our Undervalued Assets Portfolio
Mar 2
•
Greenbackd
•
2 Comments
Spicing Up the Biotech Portfolio with Microcaps CuraGen and Curis
Feb 23
•
Ohad Hammer
•
Comment!
20 Graham and Dodd Net / Nets
Jan 26
•
The Manual of Ideas
•
1 Comment
Immunogen and Seattle Genetics: Verging on an Inflection Point
May 27, 2008
•
Ohad Hammer
•
4 Comments
Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division
Mar 30, 2007
•
Centient Biotech Investor
•
1 Comment
Biotech Day In Review: Regeneron Up On AMD Data
Mar 28, 2007
•
Comment!
Curagen: A Biotech Bargain
Dec 26, 2006
•
Joseph Citarrella
•
1 Comment